- Home
- NBR vs OLMA Comparison
NBR vs OLMA Comparison
Compare NBR & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBR
- OLMA
- Stock Information
- Founded
- NBR 1952
- OLMA 2006
- Country
- NBR Bermuda
- OLMA United States
- Employees
- NBR N/A
- OLMA N/A
- Industry
- NBR Oil & Gas Production
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- NBR Energy
- OLMA Health Care
- Exchange
- NBR Nasdaq
- OLMA Nasdaq
- Market Cap
- NBR 523.7M
- OLMA 420.2M
- IPO Year
- NBR N/A
- OLMA 2020
- Fundamental
- Price
- NBR $66.51
- OLMA $5.66
- Analyst Decision
- NBR Hold
- OLMA Strong Buy
- Analyst Count
- NBR 7
- OLMA 5
- Target Price
- NBR $97.00
- OLMA $26.25
- AVG Volume (30 Days)
- NBR 328.8K
- OLMA 1.3M
- Earning Date
- NBR 02-12-2025
- OLMA 03-10-2025
- Dividend Yield
- NBR N/A
- OLMA N/A
- EPS Growth
- NBR N/A
- OLMA N/A
- EPS
- NBR N/A
- OLMA N/A
- Revenue
- NBR $2,926,108,000.00
- OLMA N/A
- Revenue This Year
- NBR N/A
- OLMA N/A
- Revenue Next Year
- NBR $13.73
- OLMA N/A
- P/E Ratio
- NBR N/A
- OLMA N/A
- Revenue Growth
- NBR N/A
- OLMA N/A
- 52 Week Low
- NBR $50.15
- OLMA $4.60
- 52 Week High
- NBR $105.96
- OLMA $16.78
- Technical
- Relative Strength Index (RSI)
- NBR 57.69
- OLMA 41.95
- Support Level
- NBR $61.92
- OLMA $4.60
- Resistance Level
- NBR $68.66
- OLMA $5.83
- Average True Range (ATR)
- NBR 3.14
- OLMA 0.54
- MACD
- NBR 1.58
- OLMA 0.15
- Stochastic Oscillator
- NBR 85.88
- OLMA 59.55
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and innovative technologies. It has operations in over 15 countries, 291 actively marketed rigs for land-based drilling operations and 28 actively marketed rigs for offshore platform drilling operations in the United States and multiple international markets. The company has five reportable segments: U.S. Drilling, Canada Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.